Published in Lancet on August 19, 1995
Endoscopy in gastrointestinal bleeding. Lancet (1974) 4.02
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut (2008) 2.32
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene (2001) 2.22
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus (2006) 1.91
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol (1998) 1.55
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr Mol Med (2009) 1.50
Left main intervention revisited: early and late outcome of PTCA and stenting. Cathet Cardiovasc Diagn (1997) 1.50
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
Sexual behaviour, drug use and hepatitis B infection in Chandigarh students. Natl Med J India (1996) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Death in acute upper gastrointestinal bleeding. Can endoscopy reduce mortality? Lancet (1976) 1.43
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
Angioplasty and acute myocardial infarction. Lancet (1993) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
Anti-thrombotic therapy for non-rheumatic atrial fibrillation. QJM (1996) 1.39
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Pulmonary embolism-an update on thrombolytic therapy. QJM (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology (2003) 1.29
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Clinical value of bile salt tests in anicteric liver disease. Gut (1981) 1.22
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Chemotaxis of a Ralstonia sp. SJ98 toward different nitroaromatic compounds and their degradation. Biochem Biophys Res Commun (2000) 1.19
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Percutaneous coronary intervention: recommendations for good practice and training. Heart (2005) 1.14
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. Br J Cancer (2009) 1.10
Sulphasalazine hepatotoxicity: lack of a hypersensitivity response. Ann Rheum Dis (1986) 1.09
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Antiplatelet rather than anticoagulant therapy with coronary stenting. Lancet (1997) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet (1970) 1.07
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J (1977) 1.06
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol (2001) 1.05
Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1996) 1.04
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol (1985) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? Br Med J (1979) 1.03
Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM (1998) 1.03
In vitro demonstration of delayed hypersensitivity to gastric antigens in pernicious anemia. Am J Dig Dis (1972) 1.03
Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol (2001) 1.03
The production of calcium and magnesium during pancreatic function tests in health and disease. Gut (1970) 1.02
Electrn microscopic observations on virus-like particles associated with SH antigen. J Virol (1970) 1.02
Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun (1999) 1.02
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Chemotaxis and biodegradation of 3-methyl- 4-nitrophenol by Ralstonia sp. SJ98. Biochem Biophys Res Commun (2000) 1.01
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry (1996) 1.01
A rare coronary anatomy comprising dual (Type IV) left anterior descending arteries and an anomalous left circumflex artery from the right coronary artery. J Invasive Cardiol (2011) 1.01
Kinetics of biodegradation of p-nitrophenol by different bacteria. Biochem Biophys Res Commun (2000) 1.00
Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther (2001) 1.00
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther (2002) 1.00
Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis (1988) 1.00
Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut (1986) 0.99